Patent Assignment
Reel/Frame 019132/0047
Change of Name
Recorded: 2007-04-06
Pages: 4
Assignor
BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE GMBH)
Executed: 2003-05-01
Assignee
SANDOZ GMBH
BIOCHEMIESTRASSE 10, KUNDL, A-6250, AUSTRIA
Covered Property
(1)
Mutilin Derivatives and Their Use as Antibacterials
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 1, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018955/0941 →
Assignment of Assignor's Interest
Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Release of Security Interest
Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →